AU2012262947A1 - Formulation of small adrenergic agonist salt forms in organic solvents - Google Patents

Formulation of small adrenergic agonist salt forms in organic solvents Download PDF

Info

Publication number
AU2012262947A1
AU2012262947A1 AU2012262947A AU2012262947A AU2012262947A1 AU 2012262947 A1 AU2012262947 A1 AU 2012262947A1 AU 2012262947 A AU2012262947 A AU 2012262947A AU 2012262947 A AU2012262947 A AU 2012262947A AU 2012262947 A1 AU2012262947 A1 AU 2012262947A1
Authority
AU
Australia
Prior art keywords
vasoconstrictor
formulation
norepinephrine
skin
formulation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012262947A
Other languages
English (en)
Inventor
William E. Fahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROCERTUS BIOPHARM Inc
Original Assignee
PROCERTUS BIOPHARM Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROCERTUS BIOPHARM Inc filed Critical PROCERTUS BIOPHARM Inc
Publication of AU2012262947A1 publication Critical patent/AU2012262947A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2012262947A 2011-06-02 2012-03-09 Formulation of small adrenergic agonist salt forms in organic solvents Abandoned AU2012262947A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161492664P 2011-06-02 2011-06-02
US61/492,664 2011-06-02
PCT/US2012/028446 WO2012166227A1 (en) 2011-06-02 2012-03-09 Formulation of small adrenergic agonist salt forms in organic solvents

Publications (1)

Publication Number Publication Date
AU2012262947A1 true AU2012262947A1 (en) 2014-01-16

Family

ID=47259712

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012262947A Abandoned AU2012262947A1 (en) 2011-06-02 2012-03-09 Formulation of small adrenergic agonist salt forms in organic solvents

Country Status (6)

Country Link
US (1) US20140343159A1 (cg-RX-API-DMAC7.html)
EP (1) EP2713988A4 (cg-RX-API-DMAC7.html)
JP (1) JP2014515400A (cg-RX-API-DMAC7.html)
CN (1) CN103764100A (cg-RX-API-DMAC7.html)
AU (1) AU2012262947A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012166227A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2990031T3 (pl) 2014-08-28 2020-05-18 Sun Pharmaceutical Industries Ltd Pozajelitowa postać norepinefryny
EP3319607A4 (en) * 2015-07-09 2019-04-03 Galderma S.A. METHOD FOR REDUCING HAIR LOSS IN CONNECTION WITH CHEMOTHERAPY
WO2020148609A1 (en) * 2019-01-10 2020-07-23 Sun Pharmaceutical Industries Limited A stable aqueous injectable solution of epinephrine
AU2022443966A1 (en) * 2022-03-04 2024-08-22 Vasodynamics Limited Topical compositions and methods.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643586A (en) * 1983-01-12 1987-02-17 Hansen Jens S Equipment and method for calibration of instruments having a temperature sensing unit
CA2154979A1 (en) * 1995-07-28 1997-01-29 Kenneth T. Armstrong Topical phenylephrine preparation
US7405080B2 (en) * 2000-03-23 2008-07-29 Voellmy Richard W Compositions and methods relating to prevention of chemotherapy-induced alopecia
US7229630B2 (en) * 2002-06-20 2007-06-12 Novalar Pharmaceuticals, Inc. Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
PT2656860T (pt) * 2005-06-17 2021-07-28 Wisconsin Alumni Res Found Preparações vasoconstritoras tópicas e métodos para proteção de células durante a quimoterapia e a radioterapia do cancro
EP1998742A2 (en) * 2006-03-08 2008-12-10 Nuviance, INC. Transdermal drug delivery compositions and topical compositions for application on the skin
EP2313037A1 (en) * 2008-06-30 2011-04-27 Oron Zachar Dermal application of vasoconstrictors
US8969331B2 (en) * 2008-10-01 2015-03-03 Roman Kelner Treatment of skin and mucosal superficial wounds using adrenergic receptor agonists

Also Published As

Publication number Publication date
JP2014515400A (ja) 2014-06-30
CN103764100A (zh) 2014-04-30
WO2012166227A1 (en) 2012-12-06
EP2713988A4 (en) 2015-03-04
EP2713988A1 (en) 2014-04-09
US20140343159A1 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
EP2704703B1 (en) Transdermal compositions of ibuprofen and methods of use thereof
JP5290582B2 (ja) 爪用医薬組成物
JP2009542657A (ja) ゲルの形態でのロピニロール含有薬学的組成物、その使用
WO2004000291A1 (en) Topical administration of basic antifungal compositions to treat fungal infections of the nails
TR201809015T4 (tr) Topikal vazokonstriktör preparasyonlar ve kanser kemoterapisi ve radyoterapisi sırasında hücreleri korumaya yönelik metotlar.
BR112012010083A2 (pt) composições farmacêuticas transdérmicas compreendendo agentes ativos
CN102770123A (zh) 用于治疗甲癣的高渗透性特比萘芬制剂
EP3202420B1 (en) Transdermal pharmaceutical compositions comprising a serm
US20100168233A1 (en) Terbinafine formulation
US20140343159A1 (en) Formulation of small adrenergic agonist salt forms in organic solvents
US20260053821A1 (en) Pharmaceutical compositions of spironolactone for deep dermal drug delivery
US20160166487A1 (en) Topical compositions for treatment of excessive sweating and methods of use thereof
CN102579322A (zh) 一种外用水凝胶剂及其制备方法与它的用途
CN101836949A (zh) 含有止吐活性药物的透皮凝胶制剂及制备方法
KR101799008B1 (ko) 케라틴 조직의 진균감염증 치료를 위한 약제학적 조성물
WO2011061155A1 (en) Antifungal formulations and their use
HK1196782A (en) Formulation of small adrenergic agonist salt forms in organic solvents
JP2951725B2 (ja) 爪白癬用外用組成物
CN120000620A (zh) 一种芦可替尼组合物及其用途
CA3221476A1 (en) Compositions and methods for treatment of alopecia areata
HK1190327B (en) Transdermal compositions of ibuprofen and methods of use thereof
HK1190327A (en) Transdermal compositions of ibuprofen and methods of use thereof
KR20150057134A (ko) 손발톱진균증 치료를 위한 테르비나핀-함유 경피흡수제제
CN101203215A (zh) 用于治疗上皮疾病的神经节阻断药

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application